Literature DB >> 18610472

History of Beta blockers in congestive heart failure.

K Swedberg.   

Abstract

Entities:  

Year:  1998        PMID： 18610472      PMCID： PMC1766483          DOI： 10.1136/hrt.79.2008.29s

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  9 in total

Review 1.  The cardiomyopathies.

Authors:  J F Goodwin; C M Oakley
Journal:  Br Heart J       Date:  1972-06

2.  Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy.

Authors:  K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal:  Br Heart J       Date:  1980-08

3.  Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Authors:  M R Bristow; R Ginsburg; V Umans; M Fowler; W Minobe; R Rasmussen; P Zera; R Menlove; P Shah; S Jamieson
Journal:  Circ Res       Date:  1986-09       Impact factor: 17.367

4.  Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade.

Authors:  K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal:  Lancet       Date:  1979-06-30       Impact factor: 79.321

5.  Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.

Authors:  F Waagstein; A Hjalmarson; E Varnauskas; I Wallentin
Journal:  Br Heart J       Date:  1975-10

6.  Reduced beta 1 receptor messenger RNA abundance in the failing human heart.

Authors:  M R Bristow; W A Minobe; M V Raynolds; J D Port; R Rasmussen; P E Ray; A M Feldman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

7.  A randomized trial of low-dose beta-blockade therapy for idiopathic dilated cardiomyopathy.

Authors:  J L Anderson; J R Lutz; E M Gilbert; S G Sorensen; F G Yanowitz; R L Menlove; M Bartholomew
Journal:  Am J Cardiol       Date:  1985-02-01       Impact factor: 2.778

8.  Beneficial effects of long-term beta-blockade in congestive cardiomyopathy.

Authors:  K Swedberg; A Hjalmarson; F Waagstein; I Wallentin
Journal:  Br Heart J       Date:  1980-08

9.  Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

Authors:  F Waagstein; M R Bristow; K Swedberg; F Camerini; M B Fowler; M A Silver; E M Gilbert; M R Johnson; F G Goss; A Hjalmarson
Journal:  Lancet       Date:  1993-12-11       Impact factor: 79.321
  9 in total
  2 in total

1.  Recent clinical data regarding the use of beta blockers in heart failure: focus on CIBIS II.

Authors:  H Dargie
Journal:  Heart       Date:  1999-12       Impact factor: 5.994

2.  Cost effectiveness of bisoprolol in the treatment of chronic congestive heart failure in Sweden: analysis using data from the Cardiac Insufficiency Bisoprolol Study II trial.

Authors:  M Ekman; N Zethraeus; B Jönsson
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.